OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
YaoYao Pollock, Matthew R. Smith, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases (2022) Vol. 26, Iss. 1, pp. 156-161
Closed Access | Times Cited: 7
YaoYao Pollock, Matthew R. Smith, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases (2022) Vol. 26, Iss. 1, pp. 156-161
Closed Access | Times Cited: 7
Showing 7 citing articles:
Global prevalence of falls among older adults with cancer: A systematic review and meta-analysis
Ganesh Bushi, Shilpa Gaidhane, Ashok Kumar Balaraman, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 3, pp. 102202-102202
Closed Access | Times Cited: 1
Ganesh Bushi, Shilpa Gaidhane, Ashok Kumar Balaraman, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 3, pp. 102202-102202
Closed Access | Times Cited: 1
Falls among geriatric cancer patients: a systematic review and meta-analysis of prevalence and risk across cancer types
Doddolla Lingamaiah, Ganesh Bushi, Shilpa Gaidhane, et al.
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access
Doddolla Lingamaiah, Ganesh Bushi, Shilpa Gaidhane, et al.
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access
Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists
Matthew J. Hadfield, Vikram Lyall, Lisa M. Holle, et al.
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 11, pp. 1302-1311
Closed Access | Times Cited: 6
Matthew J. Hadfield, Vikram Lyall, Lisa M. Holle, et al.
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 11, pp. 1302-1311
Closed Access | Times Cited: 6
Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy
Alvin Lee, Kenneth Chen, Christopher Cheng, et al.
World Journal of Urology (2023) Vol. 41, Iss. 8, pp. 2265-2271
Closed Access | Times Cited: 5
Alvin Lee, Kenneth Chen, Christopher Cheng, et al.
World Journal of Urology (2023) Vol. 41, Iss. 8, pp. 2265-2271
Closed Access | Times Cited: 5
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
John Shen, Simon Chowdhury, Neeraj Agarwal, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 73-81
Open Access | Times Cited: 5
John Shen, Simon Chowdhury, Neeraj Agarwal, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 73-81
Open Access | Times Cited: 5
Castration resistant prostate cancer: from existing therapies to compounds under investigation
Raveena Bajaj, Anil Pareek, Indranil Purkait
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 3, pp. 1014-1022
Open Access
Raveena Bajaj, Anil Pareek, Indranil Purkait
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 3, pp. 1014-1022
Open Access
Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries
Giorgia Tema, Riccardo Lombardo, Antonio Cicione, et al.
Minerva Urology and Nephrology (2023) Vol. 75, Iss. 5
Closed Access | Times Cited: 1
Giorgia Tema, Riccardo Lombardo, Antonio Cicione, et al.
Minerva Urology and Nephrology (2023) Vol. 75, Iss. 5
Closed Access | Times Cited: 1
